our services

MOMA offers a range of cutting-edge services to support research in genomics and cell biology. Our state-of-the-art facilities include:

MOMA Core Center
‍ Cell-Free and Circulating Tumor DNA Analysis
Microbiome Analyses
‍ CONNECT
‍ Single-Cell and Spatial Core Facility
RGBG
Biobank Help Center‍

Through these facilities and services, MOMA provides researchers with access to the latest technologies and expertise in genomic analysis and personalized medicine solutions

All our services are offered as non-profit for research groups and clinical departments affiliated with Aarhus University or Aarhus University Hospital.

modern technologIES

We utilize a variety of the latest technologies to advance research and development efforts.

These technologies include genome sequencing, proteomics, metabolomics, and bioinformatics. Our advanced techniques and equipment allow for a comprehensive and multidisciplinary approach to studying disease mechanisms and developing new therapeutic strategies.

Our team of experts can assist with experimental design, sample preparation, sequencing, and data analysis, ensuring high-quality results and fast turnaround times.

Contact us to learn more about how our services can support your research goals.

Services

Six lab professionals standing next to two large medical or laboratory machines with screens in a bright room.

MOMA Core Center

Next generation sequencing service

Link her
Laboratory technician wearing white gloves and lab coat operating a Bio-Rad QX200 Droplet Reader machine.

CEll freE DNA ANALYSIS

NGS & digital droplet-pcr

Link her
Magnified view of diverse colorful bacteria and viruses with DNA and RNA strands under a magnifying glass.

Microbiome Analyses

Sequencing & bioinformatics

Link her
Two people standing behind a table with promotional materials and a computer displaying information about 10 hours of free counseling, next to orange banners with Danish text related to data support and research.

Connect

research support unit

Link her
Fluorescent microscopy image of tissue cells highlighted with green, blue, and red markers outlining cell membranes and nuclei.

Single-Cell & Spatial Core

MOMA Single-Cell & Spatial Core Facility

Link her
Logo with red DNA double helix symbol next to text 'RBGB' and 'Regionernes Bio- og Genombank'.

RBGB

Bio- And Genome bank denmark

Link her
Gloved hand using tweezers to hold a vial above a purple laboratory tube rack.

Biobank Help center

MOMA Biobanks

Link her

MOMA
Department of
Molecular Medicine

Aarhus University Hospital

Brendstrupgårdsvej 21A
8200 Aarhus N, Denmark
‍

Contact

Laboratory:

+45 784 55330

Secretary:

+45 784 55310

moma@rm.dk

Molecular Medicine

Bladder CancerColorectal CancerProstate CancerRenal cancerGenetic EndocrinologyHematological CancerMMF

Bioinformatics

Computational Genomics & TranscriptomicsCancer EvolutionComputational Genomics

All

CollaborationsGraduationsPublications

Diagnostics

LaboratoryClinical BioinformaticsClinical DiagnosticsOPRA Medical Doctors

Services

MOMA Core CenterCell-free Tumor DNA analysesMicrobiome analysesConnectSingle Cell & Spatial CoreRBGBBiobank Help Center

Software

Software

Danish National Genome Center

NGC

About MOMA

FrontpageHistoryStaffSocial lifeStudy environmentJobsContact
MOMA
JW

Current Research Networks and Large Projects

Effects of Germline Structural Variation on the Biology and Pathology of the Large Intestine (2021-2024)

CIRCPAC – A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer (2020-)

UTILITY - Using liquid tumor biopsies & genetic testing to guide personalized treatment of advanced prostate cancer: From discovery to clinical care. (2020-)

TOMBOLA - Treatment of Metastatic Bladder cancer at the time of biochemical reLApse following radicial cystectomy (2020-)

DCCC ctDNA Research Center - Danish National Center for Circulating Tumor DNA Guided cancer Treatment (2020-)

DCCC Danish circulating tumor DNA network (DCCC ctDNA) (2019-)

NorDCaP  - Nordic Implementation of Personalised Prostate Cancer Diagnostics (2019-)

PRIMA - Early and accurate detection of prostate cancer in general practice (2018-)

IMPROVE - Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT - Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (2018-2025)

IMPROVE-IT2 - Implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2 (2018-2025)

"Individualized monitoring of cancer by deep sequencing of circulating tumor DNA in patients with advanced bladder cancer "(2017-)

PROCARIS - A new strategy to prevent overdiagnosis and overtreatment of non-aggressive prostate cancer in the aging male population (2016-)

PAGER - Analyzis of personal genomic rearrangements for surveillance of patients with bladder cancer (2013-)

OPRA - Oncology Precision Medicine Project Aarhus (2017-)

NEXT - Danish study of personalised cancer therapy based on tumor genetics (2017-)

""Early detection of recurrence and more curative therapy for colon cancer patients" (2016-2020)

PanCancer Analysis of Whole Genomes (PCAWG) Project (2015-)

‍

Close icon formed like a X